Corporate Overview

If you’re an investor and interested in understanding more about Cymra Life Sciences, please get in touch today: info@cymra.com.au


Strategic Pillars

We have 5 key focus areas which we refer to as our strategic pillars

How different are we?

GENETICs
& FLOWER

Locally bred genetics

  • Develop and license genetics to medical cannabis cultivators
    • Targeted strains
    • Pest and Disease resistance
    • High yield

 

Tissue Culture Services

  • Provide services to cannabis cultivators for
    •  Initiation of cultivators of genetics into TC protocols
    • Clonal maintenance

 

One of Australia’s largest cannabis genetic libraries

  • Sourced from Germany, The Netherlands, Italy, Spain, Romania, Turkey, Russia and Georgia
  • First trial crops underway and well advanced

Commercial Execution

Focus on high value parts of value chain.

  • Genetics, high value cannabis extracts – increased margins

 

Operational Northern Rivers Facility

  • Producing GMP grade organically soil grown flower 

 

Distribution Revenue and sales infrastructure

  • Existing sales through SAS Cat B 

PHARMA DRUG DEVELOPMENT

Clinical Development Plan

  • Phase II study completed
  • Pre clinical study on cell culture inflammation model for future product releases

 

Value add by developing proprietary drug

  • Chronic pain drug – subject to trial results & TGA
  • Clinical claims differentiates + increases margins

 

Experienced pharma + medical advisory team

  • Significant experience in pain + palliative care
  • Pharmaceutical experienced board of Directors

 

 

If you’re an investor and interested in understanding more about Cymra Life Sciences, please get in touch today: info@cymra.com.au

Medical Cannabis Information and Updates

Want to keep up to date with the latest Medical Cannabis Information in Australia and from around the world? We will send you informative information from time to time so you can learn about cannabis and if it can help you.